Not recruiting
Philadelphia positive chronic myeloid leukaemia
Not recruitingStudy on the Bioavailability of Nilotinib in Healthy Individuals with Chronic Myelogenous Leukemia (CML)
Registered drugNo placebo
Study on the Bioavailability of Nilotinib in Healthy Individuals with Chronic Myelogenous Leukemia (CML)
Registered drugNo placebo
- Disease:Philadelphia positive chronic myeloid leukaemia
- Substances:NilotinibNilotinib hydrochloride monohydrate
Countries:
Portugal
Portugal- Participants:18–64 years · Healthy volunteers
- Substances:Nilotinib
- Sponsor:Bluepharma Industria Farmaceutica S.A.




